Abstract
Purpose:
To evaluate the efficacy and safety of Trabectome procedure by single surgeon.
Methods:
A total of 270 cases were included in the study. Patients without pre-operative IOP were excluded. All surgeries were performed by a single surgeon (MCS). Outcome measures include IOP, number of medications and secondary glaucoma surgery, if any. Success was defined as IOP ≤ 21mmHg, IOP reduced by 20% or more from baseline on any two consecutive visits after 3 months. Kaplan-Meier was used for survival analysis.
Results:
The mean age of the study group was 71 years old. Majority were Caucasians (82%) diagnosed with primary open angle glaucoma (68%). Average baseline IOP was 23.2±7.1 mmHg with 2.4±1.2 glaucoma medications. At 6 months, the IOP was reduced to 16.9±4.0mmHg (p<0.01) and number of medications was 1.8±1.2 (p<0.01). At 12 months, the average IOP was 15.3±3.5 mmHg (p<0.01) and average number of medications was 1.5±1.2 (p<0.01). Survival at 12 months was 87%. 9 cases (3%) required additional glaucoma surgery. One case of hypotony was noted on day one, but it was quickly resolved.
Conclusions:
Trabectome appears to be safe and effective for glaucoma patients.
Keywords: 735 trabecular meshwork